Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-22

Clinical Trial Update: Effect of Butyrate Supplement on Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of a butyrate supplement in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butyrate supplement (butyrate)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED